Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.69M$2.69Mderived+236.5% vs Q4 2013 Net Income-$8.75M-$8.75MderivedN/M vs Q4 2013 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$1,274,564+570.2% Operating Incomederived-$8,730,335N/M Operating Cash Flowderived-$1,254,394N/M Free Cash Flowderived-$1,355,855N/M Margins · derivedGross margin47.3%+23.6 pt vs Q4 2013
Operating margin-324.2%−162.2 pt vs Q4 2013
Net margin-325.0%−97.1 pt vs Q4 2013
ended Dec 31, 2014 · filed Mar 31, 2015 · 90 d after period end